logo
Plus   Neg
Share
Email

Sonoma Pharmaceuticals Jumps After Benchmark Initiates At Speculative Buy

Shares of Sonoma Pharmaceuticals (SNOA) have moved sharply higher during trading on Thursday, surging up by 8.9 percent. Earlier in the session, Sonoma reached its best intraday level in three months.

The jump by Sonoma comes after Benchmark initiated coverage of the pharmaceutical company's stock with a Speculative Buy rating.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss drug major Roche Holding AG reported Wednesday higher sales in its first nine months of fiscal 2018, with growth in Pharmaceuticals sales in all regions except Europe. Diagnostics Division also recorded higher sales in all regions. Looking ahead to fiscal 2018, Roche confirmed its outlook for higher results at constant exchange rates. Online-video streaming service Netflix Inc. (NFLX), Tuesday reported a third-quarter profit that surged from last year as revenues increased 34% driven largely by strong subscriber additions. Shares surged nearly 12 percent in the after-hours trading. Netflix added 6.96 million subscribers globally... Despite opposition from the pharmaceutical industry, President Donald Trump's administration has proposed a new rule requiring companies to include the prices for prescription drug and biological products in their television advertisements.
Follow RTT